% | $
Quotes you view appear here for quick access.

Netflix, Inc. Message Board

antimachine_kudo 5 posts  |  Last Activity: Jul 9, 2016 12:24 PM Member since: Mar 10, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • antimachine_kudo antimachine_kudo Jul 9, 2016 12:24 PM Flag

    Thanks arhdan9 for posting this part for me. Initially I didn't know why yahoo wouldn't allow my to reply to my own post, and the space limit could not afford everything in one post.

    Anyhow, thanks again and good luck.

  • antimachine_kudo antimachine_kudo Jul 9, 2016 12:18 PM Flag

    It's your speculation. Can you wait for its validation or move on if you so believe, sell and find other greener pasture, or simply sue the company.

  • antimachine_kudo antimachine_kudo Jul 9, 2016 12:16 PM Flag

    It is my strong belief that there will be a major short covering coming within the next few weeks judged by current ultra-low share price (it should have never been at such a low price, no reasons, absolutely not), the closeness to a major revealing of many optional developments in the company, and the current on-going change of tide shifted from cart-t and/or CI toward DC-based therapeutic cancer vaccine treatment (cure) (note: it is my speculation)as well as the general trend of money inflow to biotech, which is on going.

    Because unless shorts have bullets penetrated their heads making them totally blinded, a major short covering must be and will be coming, even if I prefer it not!

    end of post

  • I posted it first in IHub, which got deleted twice due to some colorful words I used I guess. So I removed those words, and reposted it in Ihub this morning. In case I also post it here:

    The current development regarding FDA's order to stop Juno's pivotal P2 trial due to deaths of patients has a very significant meaning regarding the future landscape of cancer treatments:

    Cart-t as a group may have run into corner as the investment world finally come to a long overdue conclusion: this class of treatment is dangerous, cumbersome and costly, and its benefit/risk ratio is so unfavorable.

    CI as a class has shown some success with very limited treatable patient population due to its nature.

    Increasingly, more and more people will realize DCVax as a therapeutic cancer vaccine platform will emerge as a new and more broad blockbuster cancer treatment class due to its pristine safety profile and potential significant efficacy; with combinations with CIs, the platform may be potentially a cure for some cancer indications.

    At this point of time, anyone who is debating on the purpose of debating is obviously naive or up to something that a normal investor will not do. So please stop engaging in such distractions, either from an old topic which has been discussed before with no new meaning but endless new speculation; something to do with fine prints pulled out from company's sec filing which have been covered in the previous discussions; and any other FUD such as tailored, sometime out of context copies and pastes of some selected FDA documents, and ambiguous subjects such as comparing a "lackluster device" to a potential blockbuster cancer vaccine treatment in any angle negative or ambiguous possible, etc.

    Continued in next post.

  • antimachine_kudo antimachine_kudo Jul 7, 2016 8:19 PM Flag

    You are right. Hedge funds get all the spelling right but placed wrong bet in whole cart-t technologies. He may have some spelling wrong, but he seems to understand the future of cancer immunotherapy.

    For this one, I totally agree with him. NWBO is the future!

98.55+1.880(+1.94%)Sep 30 4:00 PMEDT